Octagon Capital Advisors LP

Q3 2026 13F-HR Holdings

Location
New York, NY
Holdings as of
9/30/2026
Date filed
11/16/2026
Form type
13F-HR
Num holdings
26
Total value ($000)
$750,614
Net value change ($000)
-361,925 (-32.5%)
New positions
2
Sold out positions
3
Turnover %
20.1%
Sector allocation + QoQ delta (equities-only)

Snapshot: Change Analysis

Compared to Q2 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
OBSIDIAN THERAPEUTICS INC 33,153 NEW
TNGX 15,719 NEW
ANL 4,206 39.1%
GYRE 706 11.2%
Top Reduces (Value $000, Stocks/ETFs)
ALMS -79,656 -100.0%
DFTX -43,199 -31.1%
ABVX -34,000 -25.7%
BIOA -33,626 -78.5%
DNTH -31,015 -17.3%
MIRM -25,190 -63.5%
TSHA -18,805 -28.5%
SMMT -18,213 -100.0%
AKTS -17,086 -55.2%
OCUL -15,776 -77.4%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 10,555 (1.4% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type